EKF Diagnostics HoldingsLSE:EKF +0.75%54 FCF Margin % is 12.76% as of Dec. 2025, which is 13% below its 10-year median of 14.72. GuruFocus rates LSE:EKF with a GF Score™ of 54/100 and a GF Value™ of £0.28 (Fairly Valued). The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, EKF Diagnostics Holdings ranks better than 82.94% on this metric.
The historical rank and industry rank for EKF Diagnostics Holdings's FCF Margin % or its related term are showing as below:
LSE:EKF'
s FCF Margin % Range Over the Past 10 Years
Min: -1.26 Med: 14.72 Max: 21.72
Current: 14.23
During the past 13 years, the highest FCF Margin % of EKF Diagnostics Holdings was 21.72%. The lowest was -1.26%. And the median was 14.72%.
LSE:EKF's FCF Margin % is ranked better than 82.94% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs LSE:EKF: 14.23
EKF Diagnostics Holdings FCF Margin % Related Terms
EKF Diagnostics Holdings FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, EKF Diagnostics Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EKF Diagnostics Holdings FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where EKF Diagnostics Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EKF Diagnostics Holdings (LSE:EKF) has a FCF Margin % of 12.76% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on EKF Diagnostics Holdings and its competitors. This is 13% below median its historical median of 14.72. According to the industry distribution chart, EKF Diagnostics Holdings ranks #139 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 17.1%.
Is EKF Diagnostics Holdings' FCF Margin % too high?
EKF Diagnostics Holdings' current FCF Margin % of 12.76% is 13% below median its 10-year median of 14.72. Based on the distribution chart, EKF Diagnostics Holdings ranks #139 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, EKF Diagnostics Holdings has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EKF Diagnostics Holdings ranks #139 out of 815 companies for FCF Margin %. This places EKF Diagnostics Holdings in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on EKF Diagnostics Holdings and its competitors. EKF Diagnostics Holdings's current FCF Margin % is 12.76%, which is 13% below median its own 10-year median of 14.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Fairly Valued. The stock's GF Value™ is £0.28, compared to a current price of £0.27 — trading 3.6% below its estimated fair value. The current FCF Margin % is 12.76%, which is 13% below median its 10-year median of 14.72. EKF Diagnostics Holdings' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current FCF Margin % is 12.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?
Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued.
The current stock price of £0.27 is trading 3.6% below its estimated GF Value™ of £0.28.
GuruFocus considers EKF Diagnostics Holdings to be Fairly Valued.
Key valuation signals for LSE:EKF:
FCF Margin %: 12.76% (13% below median its 10-year median of 14.72)
GF Value™: £0.28 vs. price of £0.27 (3.6% below fair value)
No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
54GF Score
Get the complete analysis for LSE:EKF
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:EKF has been successfully added to your 
